Conavi Medical Corp.
CNVI.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 70.21% | 60.86% | 23.91% | -64.98% | -- |
| Total Depreciation and Amortization | -36.10% | -36.78% | -44.12% | -21.83% | -- |
| Total Amortization of Deferred Charges | -50.80% | -63.28% | -6.08% | -20.99% | -- |
| Total Other Non-Cash Items | -105.92% | -96.06% | 5.04% | 260.54% | -- |
| Change in Net Operating Assets | -201.94% | -216.46% | -166.48% | 127.68% | -- |
| Cash from Operations | 29.06% | -4.30% | 2.53% | -17.36% | -- |
| Capital Expenditure | 89.78% | 92.21% | 66.44% | 36.97% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -105.79% | 1,396.07% | 1,432.24% | 1,608.78% | -- |
| Cash from Investing | -108.19% | 511.94% | 502.55% | 564.24% | -- |
| Total Debt Issued | -- | -- | -30.39% | 1,913.27% | -- |
| Total Debt Repaid | -10.87% | -23.69% | 7.64% | 7.53% | -- |
| Issuance of Common Stock | 19.98% | 369,966.67% | 317,100.00% | 144,071.43% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -0.06% | 270.03% | 47.14% | 5.40% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.57% | 166.96% | 1,176.27% | 3,000.77% | -- |